tradingkey.logo
tradingkey.logo

Nurexone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement

ReutersMar 26, 2026 8:49 PM

Nurexone Biologic Inc NRX.V:

  • NUREXONE STRENGTHENS U.S. MANUFACTURING STRATEGY THROUGH EXO-TOP SUBLICENSE AGREEMENT

  • NUREXONE BIOLOGIC INC - NO MONETARY CONSIDERATION OR SUBLICENSE FEES EXPECTED FOR EXO-TOP SUBLICENSE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI